Cargando…
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol: Partial Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909120/ https://www.ncbi.nlm.nih.gov/pubmed/33663138 http://dx.doi.org/10.1097/MD.0000000000024983 |
Ejemplares similares
-
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: a randomized controlled study protocol: Retraction
Publicado: (2022) -
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol
por: Yang, Linyu, et al.
Publicado: (2020) -
Retracted: Meta-Analysis of the Efficacy and Safety of Tranexamic Acid in Spinal Surgery
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Cost-Benefit Analysis of Using A Single Dose of Tranexamic Acid in Degenerative Lumbar Scoliosis Patients Undergoing Long-Segment Spinal Fusion Surgery: A Retrospective Study
por: Yuan, Lei, et al.
Publicado: (2021) -
Is combined topical with intravenous tranexamic acid superior than topical, intravenous tranexamic acid alone and control groups for blood loss controlling after total knee arthroplasty: A meta-analysis: Erratum
Publicado: (2017)